Clinical prognostic factors analysis of radiofrequency ablation on 194 cases of primary hepatocellular carcinoma

寿佳威,方勇,柴枫,梁霄,王凯峰,李世岩,田素明,潘宏铭
DOI: https://doi.org/10.13558/j.cnki.issn1672-3686.2014.02.011
2014-01-01
Abstract:Objective To investigate the survival time and prognostic factors of radiofrequency ablation (RFA)-treated hepatocellular carcinoma (HCC) patients. Methods A total of 194 HCC cases treated by RFA were retrospectively ana-lyzed. Potential prognostic factors were analyzed by Kaplan-Meier model, Log-rank test of univariate analysis and Cox re-gression model of multivariate analysis. Results The cumulative survival rates of RFA-treated HCC at 1, 3 and 5 years were 81.42%,52.65% and 41.20%, respectively. And the survival rates of small hepatocellular carcinoma that tumor size smaller than 3 cm at 1, 3 and 5 years achieved 88.47%,59.04% and 42.35%, respectively. Cox regression analysis re-vealed that child-pugh, tumor number, size, vascular tumor embolus were related to survival rate(RR=0.59,0.52,0.49, 1.79,P<0.05). The main complications included fever, abdominal pain, ascites, pleural effusion, skin burn. No RFA-related death happened. Conclusions RFA is a safe and effective treatment for HCC, especially for small ones which could achieve higher survival rate. And child-pugh, tumor number, size and vascular tumor embolus were related inde-pendently to the survival rate treating with RFA.
What problem does this paper attempt to address?